Publications by authors named "Inchang Hwang"

Background: Given the high prevalence of stage A or B heart failure (HF), comprehensive screening for new-onset HF is cost-prohibitive. Therefore, further risk stratification is warranted to identify at-risk patients. This study aimed to evaluate the prognostic utility of cardiopulmonary exercise test (CPET) with bicycle stress echocardiography (BSE) in patients with stage A or B HF.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the use of an AI-generated ECG score (ECG-GLS) to estimate left ventricular global longitudinal strain (LVGLS), which is important for diagnosing heart issues.
  • The ECG-GLS score showed strong performance in identifying patients with impaired LVGLS and comparable accuracy to traditional methods for determining LV ejection fraction (LVEF).
  • Patients with low ECG-GLS scores had significantly worse long-term outcomes, indicating that this score could serve as an effective risk assessment tool in heart failure management.
View Article and Find Full Text PDF
Article Synopsis
  • Optimal medical treatment using angiotensin receptor-neprilysin inhibitors (ARNI) can improve left ventricular ejection fraction (LVEF) in patients with heart failure with reduced EF (HFrEF), with a significant portion (46.4%) experiencing improvement after one year.
  • The study identified several factors affecting outcomes: older age, male sex, and larger heart size predicted persistent HFrEF, while atrial fibrillation and high blood pressure were inversely linked.
  • Patients with improved ejection fraction (HFimpEF) had lower rates of all-cause and cardiac mortality compared to those with persistent HFrEF (perHFrEF), suggesting that ARNI therapy leads to better overall outcomes in HFrEF
View Article and Find Full Text PDF

Background: The therapeutic effects of ertugliflozin, a sodium-glucose cotransporter 2 inhibitor, on cardiovascular outcome are not fully understood. This study aimed to evaluate the efficacy and safety of ertugliflozin on cardiac function in people with type 2 diabetes and pre-heart failure.

Methods: We conducted a 24-week randomized, double-blind, placebo-controlled trial involving individuals with type 2 diabetes inadequately controlled with antidiabetic medications.

View Article and Find Full Text PDF

Background And Objectives: Although various cardiac parameters on echocardiography have clinical importance, their measurement by conventional manual methods is time-consuming and subject to variability. We evaluated the feasibility, accuracy, and predictive value of an artificial intelligence (AI)-based automated system for echocardiographic analysis in patients with ST-segment elevation myocardial infarction (STEMI).

Methods: The AI-based system was developed using a nationwide echocardiographic dataset from five tertiary hospitals, and automatically identified views, then segmented and tracked the left ventricle (LV) and left atrium (LA) to produce volume and strain values.

View Article and Find Full Text PDF

Background: Hypertension-induced left ventricular hypertrophy (LVH) increases end-diastolic LV pressure and contributes to left atrial enlargement (LAE), which are associated with development of atrial fibrillation. However, the impact of LVH and LAE and their regression following antihypertensive therapy on atrial fibrillation incidence remains unclear.

Methods: This retrospective analysis included consecutive patients with sinus rhythm who underwent echocardiography at hypertension diagnosis and after 6-18 months between 2006 and 2021 at tertiary care centres in Korea.

View Article and Find Full Text PDF

Background: Evaluating left ventricular diastolic function (LVDF) is crucial in echocardiography; however, the complexity and time demands of current guidelines challenge clinical use. This study aimed to develop an artificial intelligence (AI)-based framework for automatic LVDF assessment to reduce subjectivity and improve accuracy and outcome prediction.

Methods: We developed an AI-based LVDF assessment framework using a nationwide echocardiographic dataset from five tertiary hospitals.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of early diastolic mitral annular tissue velocity (e') as a prognostic marker for patients with mitral regurgitation (MR).
  • It analyzed 1,536 patients under 65 years old with moderate to severe chronic primary MR, focusing on all-cause and cardiovascular mortality over a median follow-up of 6 years.
  • Findings indicate that an abnormal e' velocity (≤7 cm/s) is a significant independent predictor for both all-cause and cardiovascular death, enhancing mortality risk assessment in these patients.
View Article and Find Full Text PDF

Background: Current risk stratification strategies for patients with hypertrophic cardiomyopathy (HCM) are limited to traditional methodologies.

Objectives: The authors aimed to establish machine learning (ML)-based models to discriminate major cardiovascular events in patients with HCM.

Methods: We enrolled consecutive HCM patients from 2 tertiary referral centers and used 25 clinical and echocardiographic features to discriminate major adverse cardiovascular events (MACE), including all-cause death, admission for heart failure (HF-adm), and stroke.

View Article and Find Full Text PDF

Background/aims: : A few studies have suggested the association between (HP) infection and ischemic stroke. However, the impact of HP eradication on stroke risk has not been well evaluated. This study aimed to assess the influence of HP eradication on the incidence of ischemic stroke, considering the potential effect of sex.

View Article and Find Full Text PDF
Article Synopsis
  • - The EFFORT trial studied the use of ertugliflozin, a sodium-glucose cotransporter 2 inhibitor, to see if it could improve functional mitral regurgitation (MR) in heart failure patients with mildly to moderately reduced ejection fraction.
  • - The trial involved 128 patients receiving either ertugliflozin or a placebo while following standard heart failure treatments, measuring their MR improvement over 12 months through various cardiac metrics.
  • - Results showed that those on ertugliflozin had a significantly greater decrease in MR measurements compared to the placebo group, suggesting that ertugliflozin could effectively reduce MR and improve heart function in these patients.
View Article and Find Full Text PDF

Background: Cardiopulmonary exercise test (CPET) with supine bicycle echocardiography (SBE) enables comprehensive physiologic assessment during exercise. We characterized cardiopulmonary fitness by integrating CPET-SBE parameters and evaluated its prognostic value in patients presenting with dyspnea.

Methods And Results: We retrospectively reviewed 473 consecutive patients who underwent CPET-SBE for dyspnea evaluation.

View Article and Find Full Text PDF

Background: The association between renal dysfunction and cardiovascular outcomes has yet to be determined in patients with hypertrophic cardiomyopathy (HCM). We aimed to investigate whether mildly reduced renal function is associated with the prognosis in patients with HCM.

Methods: Patients with HCM were enrolled at two tertiary HCM centers.

View Article and Find Full Text PDF

Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular mortality and morbidity in patients with hypertension. However, the effect of age on LVH regression or persistence and its differential prognostic value remain unclear. Therefore, we investigated the clinical implications of LVH regression in 1847 patients with hypertension and echocardiography data (at baseline and during antihypertensive treatment at an interval of 6-18 months) according to age.

View Article and Find Full Text PDF

With the recent rise in violent crime, the real-time situation analysis capabilities of the prevalent closed-circuit television have been employed for the deterrence and resolution of criminal activities. Anomaly detection can identify abnormal instances such as violence within the patterns of a specified dataset; however, it faces challenges in that the dataset for abnormal situations is smaller than that for normal situations. Herein, using datasets such as UBI-Fights, RWF-2000, and UCSD Ped1 and Ped2, anomaly detection was approached as a binary classification problem.

View Article and Find Full Text PDF

Background: Despite the established benefits of angiotensin receptor-neprilysin inhibitor (ARNI) in heart failure with reduced ejection fraction (HFrEF) across various etiologies, there are controversies regarding the effects of ARNI in patients with irreversible myocardial injury. The aim of this study is to investigate the impact of irreversible myocardial injury on the benefits of ARNI treatment in patients with HFrEF, consisted of both ischemic and non-ischemic etiologies.

Methods And Results: We conducted a retrospective single-center study including 409 consecutive patients with HFrEF treated with ARNI between March 2017 and May 2020.

View Article and Find Full Text PDF

Purpose: The new version of EchoPAC platform was recently developed by General Electronics (GE) to provide 'vendor-independent' full-myocardial-layer left ventricular (LV) global longitudinal strain (LV-GLS). The agreement of the LV-GLS by two vendor-independent software platforms was investigated under diverse clinical situations.

Methods: Two-dimensional speckle-tracking LV-GLS was separately measured by two software platforms.

View Article and Find Full Text PDF

Background And Objectives: The prognostic or safety implication of renin-angiotensin-aldosterone system inhibitors (RASi) in hypertrophic cardiomyopathy (HCM) are not well established, mainly due to concerns regarding left ventricular outflow tract (LVOT) obstruction aggravation. We investigated the implications of RASi in a sizable number of HCM patients.

Methods: We enrolled 2,104 consecutive patients diagnosed with HCM in 2 tertiary university hospitals and followed up for five years.

View Article and Find Full Text PDF

Background And Purpose: Tricuspid regurgitation (TR) is a common but overlooked valvular disease, and its association with the etiologic subtypes of ischemic stroke is unclear. We explored the relationship between TR and atrial fibrillation (AF) in patients with acute ischemic stroke.

Methods: This retrospective analysis of ongoing stroke registry assessed 6,886 consecutive acute ischemic stroke patients who underwent transthoracic echocardiography during their in-hospital care.

View Article and Find Full Text PDF

Background: Contemporary cardiovascular primary prevention is based on the assessment of the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). However, the clinical implications of temporal change in the 10-year ASCVD risk estimate (∆10-year ASCVD risk/year) are unknown.

Methods: A total of 211 077 participants without established ASCVD and with repetitive 10-year ASCVD risk assessment at an interval of 4 to 5 years were selected from the Korean National Health Insurance Service data.

View Article and Find Full Text PDF

Aims: The aim of this study was to investigate the prognostic utility of left ventricular (LV) global longitudinal strain (LV-GLS) in patients with hypertrophic cardiomyopathy (HCM) and an LV ejection fraction (LVEF) of 50-60%.

Methods And Results: This retrospective cohort study included 349 patients with HCM and an LVEF of 50-60%. The primary outcome was a composite of cardiovascular death, including sudden cardiac death (SCD) and SCD-equivalent events.

View Article and Find Full Text PDF

Background And Objectives: We investigated whether the feasibility of left ventricular (LV) global longitudinal strain (GLS) in hypertrophic cardiomyopathy (HCM) varies according to the methodology (e.g. endocardial vs.

View Article and Find Full Text PDF

Background: Diabetes mellitus (DM) is a well-established risk factor for the progression of degenerative aortic stenosis (AS). However, no study has investigated the impact of glycemic control on the rate of AS progression. We aimed to assess the association between the degree of glycemic control and the AS progression, using an electronic health record-based common data model (CDM).

View Article and Find Full Text PDF